Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

dc.contributor.author	Gönczi, Lóránt
dc.contributor.author	Kürti, Zsuzsanna
dc.contributor.author	Rutka, Mariann
dc.contributor.author	Végh, Zsuzsanna
dc.contributor.author	Farkas, Klaudia
dc.contributor.author	Lovász, Barbara Dorottya
dc.contributor.author	Golovics, Petra Anna
dc.contributor.author	Gecse, Krisztina
dc.contributor.author	Szalay, Balázs
dc.contributor.author	Molnár, Tamás
dc.contributor.author	Lakatos, Péter László
dc.date.accessioned	2018-09-18T09:59:58Z
dc.date.available	2018-09-18T09:59:58Z
dc.date.issued	2017
dc.identifier	85027116826
dc.identifier.citation	pagination=97, pages: 7; journalVolume=17; journalIssueNumber=1; journalTitle=BMC GASTROENTEROLOGY;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/5942
dc.identifier.uri	doi:10.1186/s12876-017-0654-1
dc.relation.ispartof	urn:issn:1471-230X
dc.title	Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases
dc.type	Journal Article
dc.date.updated	2018-07-19T11:13:49Z
dc.language.rfc3066	en
dc.identifier.mtmt	3253720
dc.identifier.wos	000407725100003
dc.identifier.pubmed	28789636
dc.contributor.department	SE/AOK/K/I. Sz. Belgyógyászati Klinika
dc.contributor.institution	Semmelweis Egyetem